review Open AccessTop 1% cited
Genetic Pathways to Primary and Secondary Glioblastoma
American Journal Of Pathology · 2007 · Vol. 170(5) · pp. 1445–1453
Hiroko Ohgaki✉(Centre International de Recherche sur le Cancer)Paul Kleihues(University of Zurich)
Glioma Diagnosis and TreatmentCancer Mechanisms and TherapyCancer Genomics and DiagnosticsLoss of heterozygosityPTENAnaplastic astrocytomaBiologyAstrocytomaCancer researchMutationMethylationPathologyGlioma
MeSH terms
Brain NeoplasmsChromosomes, Human, Pair 10GlioblastomaHumansMutationTumor Suppressor Protein p53Loss of HeterozygosityPTEN Phosphohydrolase
Funding
- Foundation for Promotion of Cancer Research
Citations
1,473
FWCI
46.04
field-weighted impact
References
105
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Definition of Primary and Secondary Glioblastoma
Clinical Cancer Research · 2012 · 1,119 citations
The Somatic Genomic Landscape of Glioblastoma
Cell · 2013 · 5,082 citations
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Cancer Cell · 2010 · 2,346 citations
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
American Journal Of Pathology · 2009 · 1,020 citations
References
World Health Organization classification of tumors
Cancer · 2000 · 2,376 citations
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Nature Medicine · 1997 · 3,196 citations
Epidemiology and etiology of gliomas
Acta Neuropathologica · 2005 · 1,244 citations
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Nature Genetics · 1997 · 2,757 citations
The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate
Journal of Biological Chemistry · 1998 · 3,080 citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine · 2005 · 7,163 citations
CDK inhibitors: positive and negative regulators of G1-phase progression
Genes & Development · 1999 · 6,077 citations
The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
The EMBO Journal · 1998 · 1,166 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.